Primary colon cancer with a high serum PIVKA-II level
暂无分享,去创建一个
K. Onodera | M. Taniguchi | H. Furukawa | Y. Iwasaki | Kazuya Kato | Mineko Higuchi | Kimitaka Kato | Yurina Kato | M. Matsuda | Takako Kawakami | Kazuya Kato | Kimitaka Kato
[1] J. Filmus,et al. Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma. , 2011, Anti-cancer agents in medicinal chemistry.
[2] Yoshihisa Takahashi,et al. Protein induced by vitamin K absence or antagonist II-producing gastric cancer. , 2010, World journal of gastrointestinal pathophysiology.
[3] Y. Shiratori,et al. Des-γ-carboxyl Prothrombin-promoted Vascular Endothelial Cell Proliferation and Migration* , 2007, Journal of Biological Chemistry.
[4] E. Shimizu,et al. Des-gamma-carboxy prothrombin (PIVKA-II)-producing mediastinal embryonal carcinoma with features of hepatoid differentiation. , 2005, Anticancer research.
[5] M. Miyazaki,et al. PIVKA-II-producing advanced gastric cancer , 2004, International Journal of Clinical Oncology.
[6] M. Makuuchi,et al. Des-γ-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma , 2003 .
[7] R. Bast,et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Y. Shiratori,et al. Des‐γ‐carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma , 2001, Cancer.
[9] Y. Ueno,et al. Simultaneous measurements of serum α-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma , 2000, American Journal of Gastroenterology.
[10] Y. Ueno,et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. , 2000, The American journal of gastroenterology.
[11] M. Matsuda,et al. Colon cancer with a high serum alpha-fetoprotein level. , 1996, The American journal of gastroenterology.
[12] J. Belghiti,et al. Mechanism of the abnormal vitamin k‐dependent γ‐carboxylation process in human hepatocellular carcinomas , 1994, Cancer.
[13] T. Maeda,et al. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha‐fetoprotein , 1994, Cancer.
[14] J. Melamed,et al. Hepatoid adenocarcinoma in the urinary bladder. Unusual localization of a newly recognized tumor type , 1994, Cancer.
[15] M. Tsuneyoshi,et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.
[16] M. Kudo,et al. Des-γ-carboxy prothrombin (PIVKA-II) and α-fetoprotein producing IIc-type early gastric cancer , 1992 .
[17] M. Kudo,et al. Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer. , 1992, The American journal of gastroenterology.
[18] Ding‐Shinn Chen,et al. Plasma des‐γ‐carboxyprothrombin in the early stage of hepatocellular carcinoma , 1990 .
[19] J. Sung,et al. Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma. , 1990, Hepatology.
[20] Shou-Dong Lee,et al. Des-γ-Carboxy (Abnormal) Prothrombin as a Serum Marker of Primary Hepatocellular Carcinoma , 1984 .
[21] B. Furie,et al. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. , 1984, The New England journal of medicine.
[22] M. Herlyn,et al. Colorectal carcinoma antigens detected by hybridoma antibodies , 1979, Somatic cell genetics.
[23] J. Stenflo,et al. Vitamin K-dependent formation of gamma-carboxyglutamic acid. , 1977, Annual review of biochemistry.
[24] T. Waldmann,et al. Serum α-Fetoprotein in Patients with Neoplasms of the Gastrointestinal Tract , 1975 .